[{"data":1,"prerenderedAt":128},["ShallowReactive",2],{"drug-citalopram":3},{"id":4,"schemaVersion":5,"name":6,"category":9,"class":10,"brands":12,"synonyms":16,"formulations":19,"regimens":51,"contraindications":91,"warnings":108,"renal":116,"monitoring":117,"interactions":118,"review":119,"examples":122},"citalopram",1,{"fa":7,"en":8},"سیتالوپرام","Citalopram","psychiatry",{"fa":11,"en":11},"SSRI",[13],{"name":14,"market":15},"Celexa","US",[17,7,18],"celexa","سیپرالکس",[20,34,43],{"id":21,"form":22,"route":23,"label":24,"concentration":25,"markets":29,"refs":30},"tab-10","tablet","oral","10 mg tablet",{"amount":26,"unit":27,"perUnit":22,"scored":28},10,"mg",false,[15],[31],{"source":32,"section":33},"fda-celexa","3",{"id":35,"form":22,"route":23,"label":36,"concentration":37,"markets":40,"refs":41},"tab-20","20 mg tablet (scored)",{"amount":38,"unit":27,"perUnit":22,"scored":39},20,true,[15],[42],{"source":32,"section":33},{"id":44,"form":22,"route":23,"label":45,"concentration":46,"markets":48,"refs":49},"tab-40","40 mg tablet (scored)",{"amount":47,"unit":27,"perUnit":22,"scored":39},40,[15],[50],{"source":32,"section":33},[52,76],{"id":53,"disease":54,"label":55,"population":58,"type":62,"unit":27,"dose":63,"refs":66,"notes":69},"mdd-adult","mdd",{"fa":56,"en":57},"افسردگی — بزرگسال: ۲۰ mg روزانه (حداکثر ۴۰)","MDD — adults: 20 mg daily (max 40)",{"minAge":59},{"value":60,"unit":61},18,"year","titration",{"dividedDoses":5,"titration":64},{"start":38,"increment":38,"incrementEveryDays":65,"max":47},7,[67],{"source":32,"section":68},"2.1",[70],{"text":71,"refs":74},{"fa":72,"en":73},"بالای ۴۰ mg به علت طولانی شدن QT توصیه نمی‌شود.","Doses above 40 mg not recommended due to QT prolongation.",[75],{"source":32,"section":68},{"id":77,"disease":54,"label":78,"population":81,"type":83,"unit":27,"dose":84,"refs":88},"child",{"fa":79,"en":80},"کودکان","Children",{"maxAge":82},{"value":60,"unit":61},"notCalculated",{"reason":85},{"fa":86,"en":87},"بی‌خطری و اثربخشی سیتالوپرام در کودکان ثابت نشده است.","Safety and effectiveness of citalopram in pediatric patients have not been established.",[89],{"source":32,"section":90},"8.4",[92,101],{"id":93,"severity":94,"text":95,"refs":98},"maoi","block",{"fa":96,"en":97},"مصرف MAOI (شامل لینزولید یا متیلن بلو وریدی) یا تا ۱۴ روز پس از قطع آن.","Taking an MAOI (incl. linezolid or IV methylene blue) or within 14 days of stopping.",[99],{"source":32,"section":100},"4",{"id":102,"severity":94,"text":103,"refs":106},"pimozide",{"fa":104,"en":105},"مصرف پیموزاید (QT)؛ حساسیت.","Pimozide (QT prolongation); hypersensitivity.",[107],{"source":32,"section":100},[109],{"text":110,"refs":113},{"fa":111,"en":112},"هشدار جعبه‌ای: افزایش خطر افکار و رفتار خودکشی در کودکان و جوانان؛ پایش دقیق. سیتالوپرام برای کودکان تأیید نشده است.","Boxed warning: Increased risk of suicidal thoughts and behaviors in pediatric and young adult patients; monitor closely. Not approved for pediatric use.",[114],{"source":32,"section":115},"WARNING: SUICIDAL THOUGHTS AND BEHAVIORS",[],[],[],{"status":120,"reviewer":121,"date":121},"unverified",null,[123],{"regimen":53,"formulation":35,"input":124,"expect":127},{"ageYears":125,"weightKg":126},30,70,{"perDose":38,"tabletsPerDoseRounded":5},1792078533367]